Study on pharmaceutical care model for drug-related problems in elderly patients based on comprehensive medication management review

GONG Hui; LI Chen; SHAN Qing; LIU Wei; CHEN Hong; ZHAO Chuan; ZOU Hui; HUANG Zhuanqing; CHEN Mengli

doi:10.6039/j.issn.1001-0408.2023.17.20

您当前的位置：

首页 >

文章列表页 >

Study on pharmaceutical care model for drug-related problems in elderly patients based on comprehensive medication management review

更新时间：2023-09-14

- Study on pharmaceutical care model for drug-related problems in elderly patients based on comprehensive medication management review
- ZHONGGUO YAOFANG Vol. 34, Issue 17, Pages: 2162-2166(2023)
- 作者机构：
  
  1.中国人民解放军总医院医疗保障中心药剂科，北京　100853
  2.中国人民解放军总医院研究生院，北京　100853
  3.中国人民解放军总医院医学创新研究部转化医学中心，北京　100853
  4.中国人民解放军第六医学中心干部诊疗科，北京　100853
  5.中国人民解放军总医院京中医疗区门诊部，北京　100853
  6.中国人民解放军第944医院眼科，甘肃酒泉　735000
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2023.17.20
  CLC： R969.3
- Published：15 September 2023，
  
  Received：09 February 2023，
  
  Revised：29 June 2023，
扫描看全文
龚辉,李晨,单青等.基于综合药物管理评价的老年患者药物相关问题的药学服务模式探索 ^Δ[J].中国药房,2023,34(17):2162-2166.

GONG Hui,LI Chen,SHAN Qing,et al.Study on pharmaceutical care model for drug-related problems in elderly patients based on comprehensive medication management review[J].ZHONGGUO YAOFANG,2023,34(17):2162-2166.
龚辉,李晨,单青等.基于综合药物管理评价的老年患者药物相关问题的药学服务模式探索 ^Δ[J].中国药房,2023,34(17):2162-2166. DOI： 10.6039/j.issn.1001-0408.2023.17.20.

GONG Hui,LI Chen,SHAN Qing,et al.Study on pharmaceutical care model for drug-related problems in elderly patients based on comprehensive medication management review[J].ZHONGGUO YAOFANG,2023,34(17):2162-2166. DOI： 10.6039/j.issn.1001-0408.2023.17.20.

摘要

目的

基于综合药物管理评价（CMMR）探索应对老年患者药物相关问题（DRPs）的药学服务模式，并观察该模式下的药学服务效果。

方法

参考澳大利亚CMMR指南，建立老年患者药学服务新模式：临床药师通过保健医生转诊、患者或其照护者主动咨询等途径来接诊；出诊采取面诊和电话访谈相结合的方式；并采取门诊复诊、电话随访、预约上门指导等形式了解保健医生或患者对DRPs的处置情况。在该模式下，通过横断面调查老年患者DRPs的发生现状及分类，通过自身前后对照，从住院率、药品不良反应（ADR）发生率、用药依从性、用药数量、血脂水平等方面评价药学服务效果。

结果

在本研究中，形成了以患者为中心，评估-干预-再评估的闭环药学服务模式。调查结果发现，317例研究对象中，有203例（64.0%）发生了DRPs，平均每人发生DRPs 1.03（0～7）例次。采用所建立的药学服务模式干预后，与干预前对比，虽然用药数量由2.00（0.00，3.00）种增至2.00（1.00，3.00）种，但患者低密度脂蛋白胆固醇水平由3.48（2.58，4.29） mmol/L下降至3.11（2.29，3.81） mmol/L（

＜0.05）；患者1年内住院率、1年内ADR发生率、用药依从性评分变化无统计学意义（

＞0.05）。

结论

基于CMMR的药学服务模式能有效甄别并管理老年患者的DRPs，降低患者血脂水平。

Abstract

OBJECTIVE

To explore the pharmaceutical care model for elderly patients with drug-related problems （DRPs） based on the comprehensive medication management review （CMMR）， and to observe the effect of pharmaceutical care under the model.

METHODS

The pharmaceutical care new model for elderly patients was established by concerning CMMR guidelines in Australia. In other words， clinical pharmacists receive medical care through referral by health practitioners and active consultation by patients or their caregivers. Visits were made by a combination of face-to-face and telephone interviews. Follow-up was carried out in the form of outpatient follow-up， telephone follow-up， appointment， and home guidance to know about the treatment of DRPs by healthcare practitioners or patients.Under this model， the occurrence status and classification of DRPs in elderly patients were studied through cross-sectional investigation. The effect of pharmaceutical care was evaluated from the aspects of hospitalization rate， adverse drug reaction （ADR） incidence， medication compliance， the number of medications， blood lipid level， etc.， through self-before-after comparison.

RESULTS

In this study， a patient-centered， evaluation-intervention-reevaluation closed-loop pharmaceutical care model was formed. Among 317 study subjects， the average number of DRPs was 1.03 （0-7） cases. Compared before and after the intervention， the number of drug types increased from 2.00（0.00，3.00） to 2.00（1.00，3.00）， but the level of low-density lipoprotein cholesterin in patients decreased from 3.48 （2.58， 4.29） mmol/L to 3.11 （2.29，3.81） mmol/L （

＜0.05）. There was no statistical significance in hospitalization rate， ADR incidence within or medication compliance.

CONCLUSIONS

CMMR-based pharmaceutical care model can effectively identify and manage the patients’ DRPs and reduce the level of blood lipid.

关键词

药物相关问题老年患者综合药物管理评价药学服务

Keywords

elderly patientcomprehensive medication management reviewpharmaceutical care

references

FANG E F，XIE C L，SCHENKEL J A，et al. A research agenda for ageing in China in the 21st century （2nd edition）：focusing on basic and translational research，long-term care，policy and social networks[J]. Ageing Res Rev，2020，64：101174.

BHAGAVATHULA A S，VIDYASAGAR K，CHHABRA M，et al. Prevalence of polypharmacy，hyperpolypharmacy and potentially inappropriate medication use in older adults in India：a systematic review and meta-analysis[J]. Front Pharmacol，2021，12：685518.

PSA. Guidelines for comprehensive medication management reviews[EB/OL]. [2023-01-17]. https：//www.ppaonline.com.au/wp-content/uploads/2020/04/PSA-Guidelines- for-Comprehensive-Medication-Management-Reviews.pdfhttps://www.ppaonline.com.au/wp-content/uploads/2020/04/PSA-Guidelines-for-Comprehensive-Medication-Management-Reviews.pdf.

CHARLSON M E，CARROZZINO D，GUIDI J，et al. Charlson comorbidity index：a critical review of clinime- tric properties[J]. Psychother Psychosom，2022，91（1）：8-35.

郭欣颖，郝莹，张宇，等. 中文版Edmonton衰弱评估量表在住院老年病人中的信效度研究[J]. 实用老年医学，2022，36（6）：623-626，631.

吕晓英，齐士格，崔露，等. 中国社区老年人睡眠质量及影响因素调查[J/OL]. 中国医学前沿杂志（电子版），2022，14（3）：1-7（2022-03-25）[2023-01-10]. https：//kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C44YLTlOAiTRKibYlV5Vjs7iJTKGjg9uTdeTsOI_ra5_XXgwLrFoppArObnmwFEiZXxxIibgVW_f8XUUL39XZB5O&uniplatform=NZKPT. DOI：10.12037/YXQY.2022.03-01https://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C44YLTlOAiTRKibYlV5Vjs7iJTKGjg9uTdeTsOI_ra5_XXgwLrFoppArObnmwFEiZXxxIibgVW_f8XUUL39XZB5O&uniplatform=NZKPT.DOI:10.12037/YXQY.2022.03-01.

中国老年保健医学研究会老年合理用药分会，中华医学会老年医学分会，中国药学会老年药学专业委员会，等. 中国老年人潜在不适当用药判断标准：2017年版[J]. 药物不良反应杂志，2018，20（1）：2-8.

O’MAHONY D，O’SULLIVAN D，BYRNE S，et al. STOPP/START criteria for potentially inappropriate prescribing in older people：version 2[J]. Age Ageing，2014，44：213-218.

YAN J，YOU L M，YANG Q H，et al. Translation and validation of a Chinese version of the 8-item Morisky medication adherence scale in myocardial infarction patients[J]. J Eval Clin Pract，2014，20（4）：311-317.

Pharmaceutical Care Network Europe Association. Classification for drug related problems[EB/OL]. [2023-01-17].https：//www.pcne.org/upload/files/417_PCNE_classification_V9-1_final.pdfhttps://www.pcne.org/upload/files/417_PCNE_classification_V9-1_final.pdf.

NI X F，YANG C S，ZENG L N，et al. Drug-related pro- blems of children with chronic diseases in a Chinese primary health care institution：a cross-sectional study[J]. Front Pharmacol，2022，13：874948.

ZHANG S，ZHU D Q，QI Z，et al. Effects of home medication review on drug-related problems and health-related quality of life among community-dwelling older adults in China[J]. J Am Pharm Assoc，2022，62（2）：481-486.

SCHNEIDER P J，PEDERSEN C A，GANIO M C，et al. ASHP national survey of pharmacy practice in hospital settings：clinical services and workforce：2021[J]. Am J Health Syst Pharm，2022，79（18）：1531-1550.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

A qualitative study on the influencing factors of prescription circulation and its platform construction

Exploration of pharmaceutical service model in multidisciplinary diagnosis and treatment of rare diseases in children

Pharmacy construction and management of Yanqing Winter （Paralympic） Olympic Village Polyclinic for 2022 Beijing Winter （Paralympic） Olympic Games based on 4M1E method

Survey analysis of influential factors of medication compliance and adverse drug reactions of home-based patients with severe mental disorders in Jinshan district of Shanghai

Related Author

GUO Yijiao

LIU Deyang

TANG Xiaorong

HU Ming

HUANG Liang

WANG Qiqiong

CHEN Li

YU Dan

Related Institution

West China College of Pharmacy， Sichuan University

Sichuan Provincial Service Center for Medical Equipment Biding and Procurement

Dept. of Pharmacy/Evidence-Based Pharmacy Center/NMPA Key Laboratory for Technical Research on Drug Products in vitro and in vivo Correlation， West China Second University Hospital， Sichuan University

Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education

West China School of Pharmacy， Sichuan University

Address：8/F,129 Daping Main Street,Yuzhong District,Chongqing 400042,P.R.China
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰